- The United Kingdom is preparing to collect the blood from COVID-19 survivors to investigate if convalescent plasma transfusions could improve a COVID-19 patient’s speed of recovery and chances of survival.

Of 113 people with severe COVID-19 who were hospitalized at University of Chicago Medicine, all received daily infusions of remdesivir, an antiviral medicine made by Gilead Sciences, according to Stat News, which broke the story.

- A top Wuhan laboratory official has denied any role in spreading the new coronavirus, in the most high profile response from a facility at the center of months of speculation about how the previously unknown animal disease made the leap to humans.

A team of researchers at the University of Georgia College of Veterinary Medicine has developed a COVID-19 vaccine candidate that has proven successful in promoting an immune response in early test models.

THE IDEA IS TO TRICK YOUR IMMUNE SYSTEM INTO BUILDING UP DEFENSES AGAINST THE CORONAVIRUS.

The initial results of an ongoing Greek study into the benefits of the anti-inflammatory agent colchicine in treating Covid-19 are “very encouraging,” according to the scientist heading the trial.

Professor of global health at Imperial College, London warns we ‘may have to adapt’ to virus

Software suggested an arthritis drug might quell an out-of-control immune response that damages the lungs. Now it's being tested in a clinical trial.

About a month ago, Medical News Today started a series aiming to bring together the more encouraging research that emerges around COVID-19. We continue with this Special Feature that focuses on an incoming vaccine and other potential treatments for this new coronavirus and the disease it causes.

The world's largest randomised, controlled clinical trial looking at a range of potential treatments for adults hospitalized due to COVID-19 is being launched in the U.K. with more than 5,400 patients from over 165 hospitals.

The Oxford University team's experimental product, called "ChAdOx1 nCoV-19," is a type known as a recombinant viral vector vaccine, and is one of at least 70 potential COVID-19 candidate shots under development by biotech and research teams around the world.

What little we know about COVID-19 immunity, what we can intelligently guess at — and how decision makers can work with it. Plus: the United States halts funding to the World Health Organization, and mathematician and ‘Game of Life’ designer John Conway has died from COVID-19.

The first shipments of a made-in-Canada, rapid COVID-19 test will begin arriving at federal and provincial health agencies this week, following approval of the new technology by Health Canada over the Easter weekend.

As the race to find a vaccine goes on, researchers are trying potential treatments on coronavirus patients. Some show promise, some not so much.

The experimental vaccine is being tested in an early-stage trial conducted by the U.S. National Institutes of Health and Moderna expects to begin mid-stage trial in the second quarter.

The coronavirus may be “reactivating” in people who have been cured of the illness, according to Korea’s Centers for Disease Control and Prevention.

Uli von Andrian is the Mallinckrodt Professor of Immunopathology at Harvard Medical School and Program Leader of Basic Immunology at the Ragon Institute of MGH, MIT, and Harvard.

As researchers scramble to find new drugs and vaccines for Covid-19, a vaccine that is more than a century old has piqued researchers' interests. The Bacillus Calmette-Guerin vaccine -- which was first developed to fight off tuberculosis -- is being studied in clinical trials around the world as a way to fight the novel coronavirus.

A new vaccine for the novel coronavirus — which is backed by Bill and Melinda Gates — has entered phase 1 of human testing Wednesday.

Doctors are reaching for drugs that dampen the immune response — but these also undermine the body’s own fight against the coronavirus.

Four vaccine candidates—two in the US, one in China, and one in the UK—have been approved for early testing in people. Several others are close on their heels.

Hospitals in Boston, Alabama, Louisiana, Sweden and Austria are testing nitric oxide, a gas that relaxes blood vessels and could improve breathing, on patients with mild to moderate symptoms of COVID-19.

"Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.

Updates on the respiratory illness that has infected more than one million people and killed tens of thousands.

What we know and what we are still learning

Nature wades through the literature on COVID-19 so you don’t have to.

Nature’s pick of science images this month focuses on the COVID-19 outbreak.

The daily counts of COVID-19 cases and deaths tell the public story of the coronavirus outbreak. Privately, the effects of the pandemic aren’t as clear.

The world's smallest DNA analyzer," and is designed to be used "in non-laboratory settings such as airports, cruise ships, military bases, and other critical points of entry

A promising Plasma COVID-19 treatment gets fast-tracked. Arturo Casadevall and collaborators at Johns Hopkins and beyond have worked around the ...

A team of blood transfusion experts from across Canada is planning the world’s largest clinical trial of a potential treatment for COVID-19.

Survivors of COVID-19 who spent time on a ventilator may be at risk of long-term disability and illness

We know Covid-19 is an illness that disproportionately impacts some groups more than others. Namely, older people are most clearly at risk. Last ...

According to a recent study published in the New England Journal of Medicine, SARS-CoV-2, the virus that causes COVID-19, can live in the air and on surfaces between several hours and several days.

Some evidence from Europe and China suggests an overzealous immune response may be contributing to the severe illness in some patients.

Dirty air increases risk of respiratory problems that can be fatal for coronavirus patients

Early evidence of people's health conditions after one-month of lockdown in China

Japan Is Racing to Test a Drug to Treat Covid-19. Based on a compound discovered in 1998, the antiviral favipiravir is already being used in ..

Pooling patient samples for COVID-19 testing helped Stanford researchers track the early spread of the virus in the Bay Area. They found few positive cases prior to the last week of February.

If approved, the blood test could show if your immune system has developed coronavirus antibodies. But a positive result isn't a license to return to work.

G7 leaders on Friday discussed the search for a home coronavirus antibody test that could allow an early exit from the international COVID-19 lockdown.

University of Saskatchewan's Vaccine and Infectious Disease Organization has received permission from the Public Health Agency of Canada to start working on a vaccine.

How the coronavirus travels through the air has become one of the most divisive debates in this pandemic.

CNN - Ford plans to make as many as 50,000 simple ventilators for coronavirus patients within 100 days and plans to continue producing 30,000 per month after that, the company announced Monday.

Millions of doses of the anti-malarial drugs hydroxychloroquine and chloroquine will be distributed to hospitals across the country to try to slow the disease in seriously ill patients.

The deal was signed with the Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) on March 27, 2020

Abbott Laboratories is unveiling a coronavirus test that can tell if someone is infected in as little as 5 minutes, and is so small and portable it can be used in almost any health-care setting.

CNN - Dyson has received an order from the UK government for 10,000 ventilators to support efforts by the country's National Health Service to treat coronavirus patients.

Science - Scientists took conspiracy theories about SARS-CoV-2’s origins seriously, and debunked them

Nature - Radical proposal to conduct ‘human challenge’ studies could dramatically speed up vaccine research.

Dr. Francis Collins, NIH Director - Even in less challenging times, many of us try to avoid close contact with someone who is sneezing...

As the coronavirus pandemic takes hold, we are making decisions without reliable data